Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial
Portsmouth, Simon, van Veenhuyzen, David, Echols, Roger, Machida, Mitsuaki, Ferreira, Juan Camilo Arjona, Ariyasu, Mari, Tenke, Peter, Nagata, Tsutae Den
Published in The Lancet infectious diseases (01.12.2018)
Published in The Lancet infectious diseases (01.12.2018)
Get full text
Journal Article
Structured patient interview to assess clinical outcomes in complicated urinary tract infections in the APEKS-cUTI study: pilot investigation
Portsmouth, Simon, Echols, Roger, Toyoizumi, Kiichiro, Tillotson, Glenn, Nagata, Tsutae Den
Published in Therapeutic advances in infectious disease (01.11.2021)
Published in Therapeutic advances in infectious disease (01.11.2021)
Get full text
Journal Article
Designing A Pathogen-Focused Study To Address The High Unmet Medical Need Represented By Carbapenem-Resistant Gram-Negative Pathogens - The International, Multicenter, Randomized, Open-Label, Phase 3 CREDIBLE-CR Study
Bassetti, Matteo, Ariyasu, Mari, Binkowitz, Bruce, Nagata, Tsutae Den, Echols, Roger M, Matsunaga, Yuko, Toyoizumi, Kiichiro, Doi, Yohei
Published in Infection and drug resistance (01.01.2019)
Published in Infection and drug resistance (01.01.2019)
Get full text
Journal Article
Cefiderocol for treatment of complicated urinary tract infections
Portsmouth, Simon, Echols, Roger, Den Nagata, Tsutae
Published in The Lancet infectious diseases (01.01.2019)
Published in The Lancet infectious diseases (01.01.2019)
Get full text
Journal Article
Placing in-vitro heteroresistance in the context of clinical results
Bassetti, Matteo, Echols, Roger, Koren, Andrew, Karas, Andreas, Longshaw, Chris, Yamano, Yoshinori, Den Nagata, Tsutae
Published in The Lancet infectious diseases (01.07.2021)
Published in The Lancet infectious diseases (01.07.2021)
Get full text
Journal Article
Compassionate Use of Cefiderocol as Adjunctive Treatment of Native Aortic Valve Endocarditis Due to Extremely Drug-resistant Pseudomonas aeruginosa
Edgeworth, Jonathan D, Merante, Domenico, Patel, Sanjay, Young, Christopher, Jones, Paul, Vithlani, Seema, Wyncoll, Duncan, Roberts, Peter, Jones, Andrew, Den Nagata, Tsutae, Ariyasu, Mari, Livermore, David M, Beale, Richard
Published in Clinical infectious diseases (17.05.2019)
Published in Clinical infectious diseases (17.05.2019)
Get full text
Journal Article
Effect of Cefiderocol, a Siderophore Cephalosporin, on QT/QTc Interval in Healthy Adult Subjects
Sanabria, Carlos, Migoya, Elizabeth, Mason, Jay W., Stanworth, Stephanie H., Katsube, Takayuki, Machida, Mitsuaki, Narukawa, Yukitoshi, Den Nagata, Tsutae
Published in Clinical therapeutics (01.09.2019)
Published in Clinical therapeutics (01.09.2019)
Get full text
Journal Article
Prevalence of Carbapenem-Resistant Gram-Negative Infections in the United States Predominated by Acinetobacter baumannii and Pseudomonas aeruginosa
Cai, Bin, Echols, Roger, Magee, Glenn, Arjona Ferreira, Juan Camilo, Morgan, Gareth, Ariyasu, Mari, Sawada, Takuko, Nagata, Tsutae Den
Published in Open forum infectious diseases (2017)
Published in Open forum infectious diseases (2017)
Get full text
Journal Article
1266. Characterization of Shifts in Minimum Inhibitory Concentrations During Treatment with Cefiderocol or Comparators in the Phase 3 CREDIBLE-CR and APEKS-NP Studies
Takemura, Miki, Yamano, Yoshinori, Matsunaga, Yuko, Ariyasu, Mari, Echols, Roger, Den Nagata, Tsutae
Published in Open forum infectious diseases (31.12.2020)
Published in Open forum infectious diseases (31.12.2020)
Get full text
Journal Article
165. Cefiderocol Treatment for Serious Infections Caused by Carbapenem-resistant Bacteria: Post-hoc Analysis of Outcomes by Pathogen in the CREDIBLE-CR Study
Matsunaga, Yuko, Ariyasu, Mari, Takemura, Miki, Yamano, Yoshinori, Toyoizumi, Kiichiro, Kinoshita, Masahiro, Echols, Roger, Den Nagata, Tsutae
Published in Open forum infectious diseases (31.12.2020)
Published in Open forum infectious diseases (31.12.2020)
Get full text
Journal Article
1271. Efficacy and Safety of Cefiderocol and Best Available Therapy in Patients with Serious Infections Caused by Carbapenem-Resistant Gram-Negative Infections: Results of the Pathogen-Focused Phase 3 CREDIBLE-CR Study
Bassetti, Matteo, Echols, Roger, Matsunaga, Yuko, Portsmouth, Simon, Ariyasu, Mari, Toyoizumi, Kiichiro, Doi, Yohei, Den Nagata, Tsutae
Published in Open forum infectious diseases (31.12.2020)
Published in Open forum infectious diseases (31.12.2020)
Get full text
Journal Article
666. Efficacy and Safety of Cefiderocol According to Renal Impairment in Patients With Complicated Urinary Tract Infection (cUTI) in a Phase 2 Study
Portsmouth, Simon, Echols, Roger, Machida, Mitsuaki, Camilo Arjona Ferreira, Juan, Ariyasu, Mari, Den Nagata, Tsutae
Published in Open forum infectious diseases (23.10.2019)
Published in Open forum infectious diseases (23.10.2019)
Get full text
Journal Article
LB4. Efficacy and Safety of Cefiderocol vs. High-Dose Meropenem in Patients with Nosocomial Pneumonia—Results of a Phase 3, Randomized, Multicenter, Double-Blind, Non-Inferiority Study
Wunderink, Richard G, Matsunaga, Yuko, Ari, Mari, Ariyasu, Mari, Echols, Roger, Menon, Anju, Den Nagata, Tsutae
Published in Open forum infectious diseases (23.10.2019)
Published in Open forum infectious diseases (23.10.2019)
Get full text
Journal Article
1473. Structured Patient Interview in Complicated Urinary Tract Infections to Assess Clinical Outcomes vs. Investigator’s Evaluation in the APEKS-cUTI Study
Portsmouth, Simon, Toyoizumi, Kiichiro, Den Nagata, Tsutae, Tillotson, Glenn S, Echols, Roger
Published in Open forum infectious diseases (23.10.2019)
Published in Open forum infectious diseases (23.10.2019)
Get full text
Journal Article
Designing A Pathogen-Focused Study To Address The High Unmet Medical Need Represented By Carbapenem-Resistant Gram-Negative Pathogens--The International, Multicenter, Randomized, Open-Label, Phase 3 CREDIBLE-CR Study
Bassetti, Matteo, Ariyasu, Mari, Binkowitz, Bruce, Den Nagata, Tsutae, Echols, Roger M, Matsunaga, Yuko, Toyoizumi, Kiichiro, Doi, Yohei
Published in Infection and drug resistance (01.11.2019)
Published in Infection and drug resistance (01.11.2019)
Get full text
Journal Article
1316. Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol in Critically Ill Patients
Katsube, Takayuki, Kawaguchi, Nao, Matsunaga, Yuko, Ariyasu, Mari, Den Nagata, Tsutae, Portsmouth, Simon, Paterson, David, Satlin, Michael J, Zeitlinger, Markus, Echols, Roger, Wajima, Toshihiro
Published in Open forum infectious diseases (31.12.2020)
Published in Open forum infectious diseases (31.12.2020)
Get full text
Journal Article
1292. Safety Profile of the Novel Siderophore Cephalosporin Cefiderocol in Randomized Phase 2 and Phase 3 Clinical Studies of Serious Gram-Negative Infections
Matsunaga, Yuko, Sonoyama, Takuhiro, Casanova, Luis, Nagata, Tsutae Den, Echols, Roger, De Gregorio, Fabio, Ogura, Eriko, Portsmouth, Simon
Published in Open forum infectious diseases (31.12.2020)
Published in Open forum infectious diseases (31.12.2020)
Get full text
Journal Article
Burden of Carbapenem-Resistant Gram-Negative Infections in US Hospitals
Cai, Bin, Echols, Roger, Corvino, Frank, Morgan, Gareth, Van Veenhuyzen, David, Ariyasu, Mari, Sawada, Takuko, Nagata, Tsutae Den
Published in Open forum infectious diseases (01.10.2017)
Published in Open forum infectious diseases (01.10.2017)
Get full text
Journal Article
National Prevalence and Regional Variation of Carbapenem-Resistant Gram-Negative Bacteria in the Ambulatory and Acute Care Settings in the USA in 2016
Cai, Bin, Echols, Roger, Morgan, Gareth, Veenhuyzen, David Van, Ariyasu, Mari, Sawada, Takuko, Murray, John, Nagata, Tsutae Den, Gupta, Vikas
Published in Open forum infectious diseases (01.10.2017)
Published in Open forum infectious diseases (01.10.2017)
Get full text
Journal Article